2019 Continuing Education Credits

Continuing Education Credits

Continuing Education Credits up to 34.5 credit hours are awarded for the following specialties:

  • Addiction Professionals
  • Counseling
  • Nursing
  • Physicians
  • Social Work

To apply for CMEs / CEHs, conference attendees must pay the associated fee*, either in advance or at the on-site conference registration desk. Attendance at conference events will be verified electronically. Each attendee seeking continuing education credits/hours will have an electronic code attached to his/her conference badge. At the beginning of EACH session, attendees must have their badges “scanned” by room monitors in order to record continuing education credits/hours. Please note that if you leave the session early, you will be scanned out and run the risk of not getting the associated credit(s) for that session. These monitors will have electronic equipment that will automatically record each individual’s attendance in a database. The database will track and tabulate each attendee’s continuing education credits/hours. After the conference, certificates documenting attendance and the number of continuing education credits/hours earned will be electronically generated and emailed to all eligible attendees. Questions concerning Continuing Education Credits may be directed to meetings@aatod.org.

CME/CEH FEES (These fees are not included in full conference registration fee):

Physicians…………………………………………………………………….$55.00
Physician Assistants/Pharmacists/Psychologists……………….$50.00
Nurses/Social Workers……………………………………………………$45.00
Counselors……………………………………………………………………$35.00

2019 CONTINUING MEDICAL EDUCATION CREDIT
The American Society of Addiction Medicine designates this live activity for a maximum of 34.5 AMA PRA Category 1 Credit (s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American Society of Addiction Medicine and The American Association for the Treatment of Opioid Dependence (AATOD). The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.

2019 CONTINUING EDUCATION HOURS (CEHS)
ASWB—AATOD, provider #1044, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB), www.aswb.org, through the Approved Continuing Education (ACE) program. The American Association for the Treatment of Opioid Dependence (AATOD) maintains responsibility for the program. ASWB Approval Period: 6/12/19-6/12/22. Social workers should contact their regulatory board to determine course approval. Social workers participating in this course will receive up to 33.75 (clinical or social work ethics) continuing education clock hours. Please view the Conference Program for more information on specific learning outcomes and objectives, the target audience and the number of credit hours awarded for all conference sessions from ASWB.

NAADAC—AATOD is an approved provider with NAADAC, provider number 62794.

NEMSD—This continuing nursing education activity was approved by the Northeast Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. NEMSD Approver Unit has Approved Continuing Nursing Education Activity, AATOD 2019 Conference for October 19, 2019, for 33.75 Contact Hours until October 4, 2021.

A complete listing of credits approved for offered sessions is available to view here or at the CE Desk in the registration area. For more information regarding continuing education credits/hours, please email meetings@aatod.org or call 856-423-3091.

View the 2019 Faculty Disclosures here.

Visit the aatod conference website for more details…www.aatodconference.com.

@aatod1984
  • #aatod2024 ➡️ www.aatodconference.com
  • 💻 Greetings from the  #aatod2024 International Chair ➡️ bit.ly/3wjz5sf 👋 

“Buon giorno, bon jour, buenas dias, goedemorgen, boker tov, dobro utro, godan daginn, bom dia, dobro jutro, god morgon. Just a few ways to say good morning at AATOD Las Vegas. Our international colleagues are making their plans to attend, and now you have many ways to say hello. So, break out your Babel and Rosetta Stone and practice, practice, practice. A warm and friendly greeting is always welcome and a great conversation starter.” - Michael Rizzi
  • ✅ Final Reminder 

🏨 TODAY is the AATOD Room Block Reservation Deadline - Tuesday, April 30, 2024

💻 Book Your Stay for the #aatod2024 Conference ➡️ bit.ly/3wpsj45

📝 NOTE: The 2024 AATOD Conference will be held at the Planet Hollywood Resort and Casino but all sleeping rooms are soldout. Therefore, AATOD has secured an overflow block of rooms at a discounted rate allocated for AATOD conference attendees at the Paris Las Vegas Hotel and Casino, the OFFICIAL 2024 AATOD Conference Overflow Block. The negotiated rate includes a waived resort fee. These rates will be available, based on availability, until Tuesday, April 30, 2024. The government rate will not be offered within the AATOD block of rooms at the Paris Las Vegas Hotel and Casino.
  • Standard Registration Deadline:
TOMORROW - Tuesday, April 30, 2024

Don't miss out on the chance to attend the AATOD 2024 Conference, �the world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024

Register ➡️ aatodconference.com
  • AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
  • View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. 

We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication

https://youtu.be/i6u3qUS95jU
  • 💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW.

#ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
  • 💻 Webinar Recording is Now Available
AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative.  We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. 

➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
  • 3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone.

Register ➡️ bit.ly/3Vz1RPE
  • Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 

On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. 

In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  

REGISTER ➡ https://conta.cc/3TF9CSQ

View the final rule ➡ https://lnkd.in/e_iu-AtG.

There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. 

We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. 

This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW
(Director - CSAT’s Division of Pharmacologic Therapies).

The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
#aatod2024 ➡️ www.aatodconference.com
#aatod2024 ➡️ www.aatodconference.com
1 day ago
View on Instagram |
1/10
💻 Greetings from the  #aatod2024 International Chair ➡️ bit.ly/3wjz5sf 👋 

“Buon giorno, bon jour, buenas dias, goedemorgen, boker tov, dobro utro, godan daginn, bom dia, dobro jutro, god morgon. Just a few ways to say good morning at AATOD Las Vegas. Our international colleagues are making their plans to attend, and now you have many ways to say hello. So, break out your Babel and Rosetta Stone and practice, practice, practice. A warm and friendly greeting is always welcome and a great conversation starter.” - Michael Rizzi
💻 Greetings from the #aatod2024 International Chair ➡️ bit.ly/3wjz5sf 👋 “Buon giorno, bon jour, buenas dias, goedemorgen, boker tov, dobro utro, godan daginn, bom dia, dobro jutro, god morgon. Just a few ways to say good morning at AATOD Las Vegas. Our international colleagues are making their plans to attend, and now you have many ways to say hello. So, break out your Babel and Rosetta Stone and practice, practice, practice. A warm and friendly greeting is always welcome and a great conversation starter.” - Michael Rizzi
2 days ago
View on Instagram |
2/10
✅ Final Reminder 

🏨 TODAY is the AATOD Room Block Reservation Deadline - Tuesday, April 30, 2024

💻 Book Your Stay for the #aatod2024 Conference ➡️ bit.ly/3wpsj45

📝 NOTE: The 2024 AATOD Conference will be held at the Planet Hollywood Resort and Casino but all sleeping rooms are soldout. Therefore, AATOD has secured an overflow block of rooms at a discounted rate allocated for AATOD conference attendees at the Paris Las Vegas Hotel and Casino, the OFFICIAL 2024 AATOD Conference Overflow Block. The negotiated rate includes a waived resort fee. These rates will be available, based on availability, until Tuesday, April 30, 2024. The government rate will not be offered within the AATOD block of rooms at the Paris Las Vegas Hotel and Casino.
✅ Final Reminder 🏨 TODAY is the AATOD Room Block Reservation Deadline - Tuesday, April 30, 2024 💻 Book Your Stay for the #aatod2024 Conference ➡️ bit.ly/3wpsj45 📝 NOTE: The 2024 AATOD Conference will be held at the Planet Hollywood Resort and Casino but all sleeping rooms are soldout. Therefore, AATOD has secured an overflow block of rooms at a discounted rate allocated for AATOD conference attendees at the Paris Las Vegas Hotel and Casino, the OFFICIAL 2024 AATOD Conference Overflow Block. The negotiated rate includes a waived resort fee. These rates will be available, based on availability, until Tuesday, April 30, 2024. The government rate will not be offered within the AATOD block of rooms at the Paris Las Vegas Hotel and Casino.
2 days ago
View on Instagram |
3/10
Standard Registration Deadline:
TOMORROW - Tuesday, April 30, 2024

Don't miss out on the chance to attend the AATOD 2024 Conference, �the world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024

Register ➡️ aatodconference.com
Standard Registration Deadline: TOMORROW - Tuesday, April 30, 2024 Don't miss out on the chance to attend the AATOD 2024 Conference, �the world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024 Register ➡️ aatodconference.com
3 days ago
View on Instagram |
4/10
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️  TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations. We certainly hope that this is helpful and please let us know if you have any questions.
2 weeks ago
View on Instagram |
5/10
View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. 

We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication

https://youtu.be/i6u3qUS95jU
View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication https://youtu.be/i6u3qUS95jU
3 weeks ago
View on Instagram |
6/10
💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW.

#ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW. #ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
3 weeks ago
View on Instagram |
7/10
💻 Webinar Recording is Now Available
AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative.  We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. 

➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
💻 Webinar Recording is Now Available AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative. We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. ➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
4 weeks ago
View on Instagram |
8/10
3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone.

Register ➡️ bit.ly/3Vz1RPE
3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone. Register ➡️ bit.ly/3Vz1RPE
1 month ago
View on Instagram |
9/10
Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 

On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. 

In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  

REGISTER ➡ https://conta.cc/3TF9CSQ

View the final rule ➡ https://lnkd.in/e_iu-AtG.

There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. 

We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. 

This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW
(Director - CSAT’s Division of Pharmacologic Therapies).

The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  REGISTER ➡ https://conta.cc/3TF9CSQ View the final rule ➡ https://lnkd.in/e_iu-AtG. There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW (Director - CSAT’s Division of Pharmacologic Therapies). The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
1 month ago
View on Instagram |
10/10

AVAILABLE 🗒️ TECHNICAL REVIEW OF @SAMHSA’S FINAL REGS ➡️ http://bit.ly/3w71hOM
This brief can be used by treatment providers/state officials as a quick reference in better understanding the salient policy issues in the new regs. We hope that this is helpful.

Load More...

#aatod2024 Conference – Las Vegas

COUNTDOWN

2024 Conference

AATOD, Inc.
225 Varick Street, Suite 402
New York, New York 10014

Contact Us
Phone : 212-566-5555
Email : info@aatod.org

Social Sharing
RSS
Follow by Email
Facebook
Twitter
YouTube
LinkedIn
Instagram
Stay Connected to AATOD